Recent advances in cell membrane-based biomimetic delivery systems for Parkinson’s disease: Perspectives and challenges
Neuroinflammation, α-synuclein pathology and dopaminergic cell loss are the hallmarks of Parkinson’s disease (PD), an incurable movement disorder. The presence of the blood-brain barrier (BBB) impedes the delivery of therapeutics and makes the design of drug-targeting delivery vehicles challenging....
Saved in:
| Main Authors: | Jasleen Kaur, Abhishek Thakran, Saba Naqvi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Asian Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087625000443 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane-based biomimetic delivery systems for glioblastoma multiforme therapy
by: Lv Guangyao, et al.
Published: (2025-06-01) -
Lipid-based nanoparticles for drug delivery in Parkinson’s disease
by: Cai Han, et al.
Published: (2024-12-01) -
Recent Advances in the Delivery of Bone Morphogenetic Proteins for Targeting Glioma: An Updated Review
by: Bao H, et al.
Published: (2025-05-01) -
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
by: Anikó Szecskó, et al.
Published: (2025-04-01) -
Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles
by: Ramesha Hanumanthappa, et al.
Published: (2024-12-01)